Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8824 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8488 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8439 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8373 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8314 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8286 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8266 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8222 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8114 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8107 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8081 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8046 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7989 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7989 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7901 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7862 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7849 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7814 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7789 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7753 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7725 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7725 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7725 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7706 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7705 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7674 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7667 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.765 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7633 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD37 |
Approved |
0.7598 |
Intermediate Similarity |
NPD7228 |
Approved |
0.759 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7572 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7526 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7526 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7474 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7469 |
Intermediate Similarity |
NPD943 |
Approved |
0.7458 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7427 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7416 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7401 |
Intermediate Similarity |
NPD919 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD3750 |
Approved |
0.736 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7351 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7326 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7323 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.725 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7247 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7182 |
Intermediate Similarity |
NPD5710 |
Approved |
0.717 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD1607 |
Approved |
0.716 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD2800 |
Approved |
0.711 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7104 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7076 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6977 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD6651 |
Approved |
0.6952 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6932 |
Remote Similarity |
NPD920 |
Approved |
0.6928 |
Remote Similarity |
NPD3764 |
Approved |
0.6928 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD9268 |
Approved |
0.6901 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6869 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6859 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD9545 |
Approved |
0.6854 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6848 |
Remote Similarity |
NPD9494 |
Approved |
0.6845 |
Remote Similarity |
NPD1613 |
Approved |
0.6845 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD6099 |
Approved |
0.6842 |
Remote Similarity |
NPD5406 |
Approved |
0.6842 |
Remote Similarity |
NPD5404 |
Approved |
0.6842 |
Remote Similarity |
NPD5408 |
Approved |
0.6842 |
Remote Similarity |
NPD5405 |
Approved |
0.6842 |
Remote Similarity |
NPD6100 |
Approved |
0.6834 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD2403 |
Approved |
0.6825 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6821 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD7680 |
Approved |
0.6805 |
Remote Similarity |
NPD1933 |
Approved |
0.6804 |
Remote Similarity |
NPD8360 |
Approved |
0.6804 |
Remote Similarity |
NPD8435 |
Approved |
0.6804 |
Remote Similarity |
NPD8361 |
Approved |
0.6798 |
Remote Similarity |
NPD7584 |
Approved |
0.6786 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6777 |
Remote Similarity |
NPD7907 |
Approved |
0.6774 |
Remote Similarity |
NPD5242 |
Approved |
0.6758 |
Remote Similarity |
NPD5353 |
Approved |
0.6746 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6739 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD7930 |
Approved |
0.673 |
Remote Similarity |
NPD9493 |
Approved |
0.6727 |
Remote Similarity |
NPD1470 |
Approved |
0.6724 |
Remote Similarity |
NPD1243 |
Approved |
0.672 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.672 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6703 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD1201 |
Approved |
0.6687 |
Remote Similarity |
NPD2798 |
Approved |
0.6686 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6686 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6683 |
Remote Similarity |
NPD5005 |
Approved |
0.6683 |
Remote Similarity |
NPD5006 |
Approved |
0.6682 |
Remote Similarity |
NPD4665 |
Approved |
0.6682 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD5028 |
Approved |
0.6667 |
Remote Similarity |
NPD5026 |
Approved |
0.6667 |
Remote Similarity |
NPD36 |
Approved |
0.6667
|
Remote Similarity |
NPD4955 |
Approved |